Isy Goldwasser is a seasoned executive in the biotechnology and life sciences sectors, currently serving as Chief Executive Officer at OmRx Oncology, Inc. and Calibr Bioventures. Goldwasser's previous roles include Entrepreneur In Residence at Scripps Research, Advisor to CEO at CapsoVision, Inc., and CEO at thync, among other significant positions. Extensive experience includes a leadership tenure at Symyx Technologies, where Goldwasser held roles as CEO, President, and Vice President of Business Development. Educational qualifications include a Master of Science in Chemical Engineering from Stanford University and a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology.
Sign up to view 0 direct reports
Get started